Literature DB >> 22189757

The major plant-derived cannabinoid Δ(9)-tetrahydrocannabinol promotes hypertrophy and macrophage infiltration in adipose tissue.

A Wong1, N Gunasekaran, D P Hancock, G S Denyer, L Meng, J L Radford, I S McGregor, J C Arnold.   

Abstract

Synthetic cannabinoid receptor agonists activate lipoprotein lipase and the formation of lipid droplets in cultured adipocytes. Here we extend this work by examining whether Δ(9)-tetrahydrocannabinol (THC), a major plant-derived cannabinoid, increases adipocyte size in vivo. Further, possibly as a consequence of hypertrophy, we hypothesize that THC exposure promotes macrophage infiltration into adipose tissue, an inflammatory state observed in obese individuals. Rats repeatedly exposed to THC in vivo had reduced body weight, fat pad weight, and ingested less food over the drug injection period. However, THC promoted adipocyte hypertrophy that was accompanied by a significant increase in cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) expression, an enzyme important in packaging triglycerides. We also showed that THC induced macrophage infiltration and increased expression of the inflammatory cytokine tumor necrosis factor alpha (TNF-α) in adipose tissue but did not induce apoptosis as measured by TUNEL staining. That THC increased adipocyte cell size in the absence of greater food intake, body weight and fat provides a unique model to explore mechanisms underlying changes in adipocyte size associated with a mild inflammatory state in fat tissue. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189757     DOI: 10.1055/s-0031-1297940

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats.

Authors:  Sean B Ogden; Michael S Malamas; Alexandros Makriyannis; Lisa A Eckel
Journal:  Br J Pharmacol       Date:  2019-09-06       Impact factor: 8.739

2.  Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.

Authors:  Dai Lu; Rachel Dopart; Debra A Kendall
Journal:  Cell Stress Chaperones       Date:  2016-01       Impact factor: 3.667

3.  The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies.

Authors:  Frances R Henshaw; Lauren S Dewsbury; Chai K Lim; Genevieve Z Steiner
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-28

4.  Self-reported marijuana use over 25 years and abdominal adiposity: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Michael P Bancks; Reto Auer; J Jeffrey Carr; David C Goff; Catarina Kiefe; Jamal S Rana; Jared Reis; Stephen Sidney; James G Terry; Pamela J Schreiner
Journal:  Addiction       Date:  2017-12-07       Impact factor: 7.256

5.  Metabolic effects of chronic cannabis smoking.

Authors:  Ranganath Muniyappa; Sara Sable; Ronald Ouwerkerk; Andrea Mari; Ahmed M Gharib; Mary Walter; Amber Courville; Gail Hall; Kong Y Chen; Nora D Volkow; George Kunos; Marilyn A Huestis; Monica C Skarulis
Journal:  Diabetes Care       Date:  2013-03-25       Impact factor: 19.112

Review 6.  Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.

Authors:  Thomas Murphy; Bernard Le Foll
Journal:  Biomolecules       Date:  2020-06-04

Review 7.  Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review.

Authors:  Nathan Fearby; Samantha Penman; Panayotis Thanos
Journal:  Int J Environ Res Public Health       Date:  2022-03-08       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.